Innovative developments in pain and anxiety management for the infertile and endometriosis patient

In: Vrije Universiteit Amsterdam · 2026 · doi:10.5463/thesis.1642 · W7160709687
OA: green CC0
⚙ AI-generated summary by qwen3.7-flash, 2026-09-28 ⓘ

This thesis evaluates innovative pain and anxiety management for infertile and endometriosis patients, finding Virtual Reality effective in specific contexts, Spinal Cord Stimulation reducing symptoms in intractable endometriosis, and dietary interventions improving quality of life.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-09-28 · read from full text ⓘ

This thesis evaluates innovative pain and anxiety management strategies for patients with infertility and endometriosis, covering virtual reality applications, spinal cord stimulation guidelines, and dietary interventions. It finds that while virtual reality shows mixed efficacy for procedural pain during gynecological procedures, spinal cord stimulation effectively reduces chronic pelvic pain and improves quality of life in women with intractable endometriosis symptoms. Additionally, the research indicates that adherence to specific endometriosis-focused diets can significantly alleviate pain and improve well-being, whereas gluten-free diets lack sufficient evidence for general recommendation in this population. This paper is centrally about endometriosis — specifically focusing on non-pharmacological and neuromodulatory approaches to managing chronic pain and anxiety associated with the condition.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

This thesis centers around alleviating pain and anxiety, and thereby optimizing patient experiences, in the infertile and endometriosis patient. We focused on innovative approaches like Virtual Reality (VR) and Spinal Cord Stimulation (SCS), but also self-management strategies including dietary interventions. The results are presented in three parts. Part I: Pain and anxiety management using Virtual Reality in the infertile patient In Chapter 2 a systematic review with meta-analysis on the appliance of VR in (outpatient) gynaecological procedures was performed. A reduction in worst pain and procedural anxiety was seen, in favour of VR. All satisfaction scores were high with no significant difference between VR and non-VR. In Chapter 3 we studied the effect of VR on pain during hysterosalpingography (HSG). We found no disparity in reported average and worst pain scores between VR and non-VR. Nonetheless, women undergoing HSG with VR were significantly less willing to undergo another HSG without VR. In Chapter 4 we evaluated the efficacy of VR on pain and anxiety management during oocyte retrieval in IVF/ICSI treatment. We found no significant differences in anxiety, overall pain and peak pain between VR and non-VR. When looking at retrievals where 10 follicles or less were collected, we did see a significant benefit of VR on overall pain. Part II: Standardizing pain management and the appliance of Spinal Cord Stimulation in endometriosis In Chapter 5 we performed a multidisciplinary consensus meeting followed by an eDELPHI procedure to reach national consensus and a step-by-step guideline for pain management in endometriosis patients. The first two steps adhere to the WHO step-by-step approach, the third step consists of the addition of Tricyclic Antidepressants (TCAs) in case of neuropathic pain. Both the use of metamizol and opioids are recommended to only be used short-term. Muscarinic receptor antagonists are accepted treatment for bladder endometriosis. The use of COX-2 inhibitors were suggested but not presented as an established step. It was advised to prescribe magnesium oxide with all types of pain management because of their positive effect on gastro-intestinal symptoms. Proton pump inhibitors (PPIs) should be prescribed with use of NSAIDs, also when incidental. In Chapter 6 we collected all evidence regarding the appliance of SCS for visceral pain, between a broad number of diagnoses. We concluded that SCS applied for visceral pain could be effective in reducing symptoms, improving QoL and in reducing or even discontinuing pain medication use. In Chapter 7 we performed a feasibility pilot study, where SCS was applied in women diagnosed with endometriosis and intractable pain. SCS was effective in reducing general and worst pain, dysmenorrhea, chronic pelvic pain, dysuria and dyschezia. We saw improvements in QoL. All participants but one were able to reduce their analgesics. One participant requested device explantation. Part III: Dietary interventions in the chronic endometriosis patients In Chapter 8 we performed a survey study on the effect of the endometriosis diet on QoL. We found that the endometriosis diet positively influenced QoL, even more so when there was strict adherence. In Chapter 9 we studied the efficacy of the endometriosis diet and Low FODMAP diet on pain and QoL. We found that a diet positively influenced deep dyspareunia, dysuria, bloating and tiredness and improved QoL. In Chapter 10 we discussed why a glutenfree diet should not be recommended to women solely diagnosed with endometriosis. Its efficacy is based on only one study without a control group and without testing the participants for coeliac disease. Therefore it is possible that a strong placebo and nocebo effect plays a crucial role in the effectiveness of a glutenfree diet.
Full text 4,644 characters · extracted from oa-html · 2 sections · click to expand

Abstract

This thesis centers around alleviating pain and anxiety, and thereby optimizing patient experiences, in the infertile and endometriosis patient. We focused on innovative approaches like Virtual Reality (VR) and Spinal Cord Stimulation (SCS), but also self-management strategies including dietary interventions. The results are presented in three parts. Part I: Pain and anxiety management using Virtual Reality in the infertile patient In Chapter 2 a systematic review with meta-analysis on the appliance of VR in (outpatient) gynaecological procedures was performed. A reduction in worst pain and procedural anxiety was seen, in favour of VR. All satisfaction scores were high with no significant difference between VR and non-VR. In Chapter 3 we studied the effect of VR on pain during hysterosalpingography (HSG). We found no disparity in reported average and worst pain scores between VR and non-VR. Nonetheless, women undergoing HSG with VR were significantly less willing to undergo another HSG without VR. In Chapter 4 we evaluated the efficacy of VR on pain and anxiety management during oocyte retrieval in IVF/ICSI treatment. We found no significant differences in anxiety, overall pain and peak pain between VR and non-VR. When looking at retrievals where 10 follicles or less were collected, we did see a significant benefit of VR on overall pain. Part II: Standardizing pain management and the appliance of Spinal Cord Stimulation in endometriosis In Chapter 5 we performed a multidisciplinary consensus meeting followed by an eDELPHI procedure to reach national consensus and a step-by-step guideline for pain management in endometriosis patients. The first two steps adhere to the WHO step-by-step approach, the third step consists of the addition of Tricyclic Antidepressants (TCAs) in case of neuropathic pain. Both the use of metamizol and opioids are recommended to only be used short-term. Muscarinic receptor antagonists are accepted treatment for bladder endometriosis. The use of COX-2 inhibitors were suggested but not presented as an established step. It was advised to prescribe magnesium oxide with all types of pain management because of their positive effect on gastro-intestinal symptoms. Proton pump inhibitors (PPIs) should be prescribed with use of NSAIDs, also when incidental. In Chapter 6 we collected all evidence regarding the appliance of SCS for visceral pain, between a broad number of diagnoses. We concluded that SCS applied for visceral pain could be effective in reducing symptoms, improving QoL and in reducing or even discontinuing pain medication use. In Chapter 7 we performed a feasibility pilot study, where SCS was applied in women diagnosed with endometriosis and intractable pain. SCS was effective in reducing general and worst pain, dysmenorrhea, chronic pelvic pain, dysuria and dyschezia. We saw improvements in QoL. All participants but one were able to reduce their analgesics. One participant requested device explantation. Part III: Dietary interventions in the chronic endometriosis patients In Chapter 8 we performed a survey study on the effect of the endometriosis diet on QoL. We found that the endometriosis diet positively influenced QoL, even more so when there was strict adherence. In Chapter 9 we studied the efficacy of the endometriosis diet and Low FODMAP diet on pain and QoL. We found that a diet positively influenced deep dyspareunia, dysuria, bloating and tiredness and improved QoL. In Chapter 10 we discussed why a glutenfree diet should not be recommended to women solely diagnosed with endometriosis. Its efficacy is based on only one study without a control group and without testing the participants for coeliac disease. Therefore it is possible that a strong placebo and nocebo effect plays a crucial role in the effectiveness of a glutenfree diet. | Original language | English | |---|---| | Qualification | PhD | | Awarding Institution | - Vrije Universiteit Amsterdam | | Supervisors/Advisors | - Mijatovic, Velimir, Supervisor, - - Kallewaard, J.W., Co-supervisor, - - Schreurs, Anneke Margaretha Francisca, Co-supervisor, - | | Award date | 3 Jun 2026 | | Print ISBNs | 9789465343228 | | DOIs | | | Publication status | Published - 3 Jun 2026 |

Keywords

- Endometriosis - infertility - pain management - anxiety management - Virtual Reality - neuromodulation - dietary interventions Fingerprint Dive into the research topics of 'Innovative developments in pain and anxiety management for the infertile and endometriosis patient'. Together they form a unique fingerprint.Cite this - APA - Author - BIBTEX - Harvard - Standard - RIS - Vancouver

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisbladder_endometriosischronic_pelvic_paindysmenorrheadyspareunia

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-08-09T06:04:05.141522+00:00
License: CC0 · commercial use OK